Amgen, Inc. (AMGN)
339.17
+3.23
(+0.96%)
USD |
NASDAQ |
May 27, 13:07
Amgen Cash from Investing (Quarterly) : -716.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen, Inc. | -209.50M |
| Gilead Sciences, Inc. | 1.77B |
| Regeneron Pharmaceuticals, Inc. | -428.90M |
| AbbVie, Inc. | -574.00M |
| Moderna, Inc. | -76.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.189B |
| Cash from Financing (Quarterly) | 1.436B |
| Free Cash Flow | 8.597B |
| Free Cash Flow Per Share (Quarterly) | 2.715 |
| Free Cash Flow to Equity (Quarterly) | -411.00M |
| Free Cash Flow to Firm (Quarterly) | 2.063B |
| Free Cash Flow Yield | 4.67% |